Aclarion, Inc. (ACONW) Financial Statements (2026 and earlier)

Company Profile

Business Address 8181 ARISTA PLACE
BROOMFIELD, CO 80021
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12,0164541,0211,473
Cash and cash equivalent12,0164541,0211,473
Receivables30181319
Deferred costs   205 
Other current assets    
Other undisclosed current assets35135250497
Total current assets:12,3978241,2891,988
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization24523
Intangible asset, including goodwill, after accumulated amortization1,2521,2941,1691,214
Intangible asset, excluding goodwill, after accumulated amortization1,2521,2941,1691,214
Total noncurrent assets:1,2761,2991,1701,218
Other undisclosed assets    0
TOTAL ASSETS:13,6722,1232,4603,206
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3335327611,073
Accounts payable333532761462
Accrued liabilities    611
Debt   1,126 
Derivative instruments and hedges, liabilities0 121 
Other undisclosed current liabilities5046221,180345
Total current liabilities:8371,1533,1881,418
Noncurrent Liabilities
Total liabilities:8371,1533,1881,418
Equity
Equity, attributable to parent, including:12,835970(728)1,788
Common stock  00
Additional paid in capital71,33152,23243,55441,695
Accumulated deficit(58,496)(51,262)(44,282)(39,907)
Other undisclosed equity, attributable to parent 0  (0)
Total equity:12,835970(728)1,788
Other undisclosed liabilities and equity    0
TOTAL LIABILITIES AND EQUITY:13,6722,1232,4603,206

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Revenues76467560
Cost of revenue(69)(85)(76)(65)
Gross profit:7(39)(0)(5)
Operating expenses(7,059)(5,474)(4,876)(6,094)
Operating loss:(7,052)(5,513)(4,876)(6,099)
Nonoperating income (expense)(181)(1,480)(35)(1,507)
Interest and debt expense  (112)(608)(1,508)
Loss from continuing operations before equity method investments, income taxes:(7,234)(7,105)(5,520)(9,113)
Other undisclosed income from continuing operations before income taxes  112608 
Loss from continuing operations:(7,234)(6,993)(4,911)(9,113)
Other undisclosed net income (loss) (7)  1,508
Net loss:(7,240)(6,993)(4,911)(7,606)
Other undisclosed net income attributable to parent 7   
Net loss attributable to parent:(7,234)(6,993)(4,911)(7,606)
Preferred stock dividends and other adjustments (7)(60) (416)
Other undisclosed net income available to common stockholders, basic    0
Net loss available to common stockholders, diluted:(7,240)(7,053)(4,911)(8,021)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Net loss:(7,240)(6,993)(4,911)(7,606)
Comprehensive loss, net of tax, attributable to parent:(7,240)(6,993)(4,911)(7,606)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: